Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Cardiovascular Risk”

1,352 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,352 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04088292
What this trial is testing

Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism

Who this might be right for
Pulmonary Embolism
Rigshospitalet, Denmark 210
Not applicableStudy completedNCT01690312
What this trial is testing

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Who this might be right for
Cardiovascular Disease
Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 36
Not applicableActive Not RecruitingNCT04011722
What this trial is testing

Portico Next Generation Approval Study

Who this might be right for
Symptomatic Severe Aortic Stenosis
Abbott Medical Devices 333
Not applicableStudy completedNCT03817801
What this trial is testing

Comparison of Scoring Balloon and Conventional Balloon Predilation Before Drug Coated Balloon for de Novo Lesion in Patients With High Bleeding Risk

Who this might be right for
Coronary Artery Disease
Nanjing First Hospital, Nanjing Medical University 60
Not applicableEnded earlyNCT03246243
What this trial is testing

Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High Risk

Who this might be right for
Hypoxic-Ischemic EncephalopathyHypoglycemiaNeonatal Abstinence Syndrome
Boston Children's Hospital 16
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Not applicableLooking for participantsNCT07226609
What this trial is testing

A Dietary Study for People With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 220
Not applicableUnknownNCT01383304
What this trial is testing

Aspirin Response in High Risk Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery DiseaseMyocardial InfarctionDiabetes Mellitus+1 more
University of Aarhus 906
Not applicableNot Yet RecruitingNCT07015021
What this trial is testing

The Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM Patients

Who this might be right for
Multiple MyelomaCarfilzomibDaratumumab+1 more
The First Affiliated Hospital of Soochow University 72
Post-approval studies (Phase 4)Study completedNCT00346216
What this trial is testing

Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen

Who this might be right for
Arthritis, Rheumatoid
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 24,081
Testing effectiveness (Phase 2)Study completedNCT01839916
What this trial is testing

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more
University of Chicago 77
Post-approval studies (Phase 4)Ended earlyNCT02601664
What this trial is testing

Randomized-controlled Trial of a Combined vs. Conventional Percutaneous Intervention for Near-Infrared Spectroscopy Defined High-Risk Native Coronary Artery Lesions

Who this might be right for
ArteriosclerosisNear-infrared SpectroscopyPeri-procedural Myocardial Infarction+1 more
North Texas Veterans Healthcare System 3
Large-scale testing (Phase 3)Study completedNCT00402506
What this trial is testing

A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG

Who this might be right for
Coronary Artery Bypass Graft SurgeryMyocardial IschemiaReperfusion Injury
Medicure 3,000
Not applicableStudy completedNCT01011504
What this trial is testing

Utilisation of Angiox® in European Practice

Who this might be right for
Stable Angina (SA)NSTE-ACS (NSTEMI and UA)STEMI (STE-ACS)
The Medicines Company 2,019
Large-scale testing (Phase 3)Looking for participantsNCT07000357
What this trial is testing

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 15,100
Not applicableStudy completedNCT03717363
What this trial is testing

Training Programme in Physical Activity

Who this might be right for
Cardiovascular Risk FactorCardiovascular Disease
Hospital Mutua de Terrassa 147
Not applicableStudy completedNCT00005695
What this trial is testing

Physical Training and Blood Pressure in High Risk Youths

Who this might be right for
Cardiovascular DiseasesHeart DiseasesHypertension+1 more
Augusta University
Not applicableStudy completedNCT01164371
What this trial is testing

Gender Differences in the Development, Treatment and Prognosis of Coronary Disease: A CALIBER Study

Who this might be right for
Coronary DiseaseCardiovascular Disease
University College, London 1,758,584
Large-scale testing (Phase 3)Not Yet RecruitingNCT07242599
What this trial is testing

Ongericimab Injection Reducing Recurrence of Ischemic Stroke

Who this might be right for
Ischemic Cerebral Infarction
Beijing Tiantan Hospital 4,810
Not applicableStudy completedNCT01240512
What this trial is testing

DAYLIGHT: Vitamin D Therapy in Individuals at High Risk of Hypertension

Who this might be right for
HypertensionVitamin D DeficiencyPre-Hypertension
Massachusetts General Hospital 534
Load More Results